UDP-N-acetylglucosamine (UDP-GlcNAc
T
he Kdo 2 -lipid A substructure ( Fig. 1 ) of LPS is required for the growth of most Gram-negative bacteria and accounts for the some of the toxic side-effects of Gram-negative sepsis (1) (2) (3) (4) . In Escherichia coli, UDP-N-acetylglucosamine (UDP-GlcNAc) acyltransferase (LpxA) catalyzes the first step of lipid A biosynthesis (5-7), the reversible transfer of the R-3-hydroxymyristoyl moiety from R-3-hydroxymyristoyl-acyl carrier protein (ACP) to the glucosamine 3-OH group of UDP-GlcNAc ( Fig. 1) (8) . Because LpxA catalyzes a thermodynamically unfavorable reaction (K eq Ϸ 0.01) (8) , the second enzyme of the pathway, the deacetylase (LpxC), is the committed step (9, 10) . LpxA and LpxC are essential for growth (10) (11) (12) , and both are validated targets for the design of novel antibiotics (13) (14) (15) .
UDP-GlcNAc acyltransferases are soluble cytoplasmic proteins (8, 16, 17) . They usually require R-hydroxyacyl-ACP as donor substrates (6, 8, 18) . Although highly selective for R-3-hydroxymyristoyl-ACP, E. coli LpxA utilizes R-3-hydroxylauroyl-ACP and R-3-hydroxypalmitoyl-ACP at 1-2% the rate of R-3-hydroxymyristoyl-ACP under standard assay conditions (6, 18, 19) . R-3-hydroxydecanoyl-ACP is used at Ϸ0.1% the rate of R-3-hydroxymyristoyl-ACP (18, 19) . Pseudomonas aeruginosa LpxA is maximally active with R-3-hydroxydecanoyl-ACP, which it prefers over R-3-hydroxymyristoyl-ACP by a factor of 1,000 (18) (19) (20) . The in vitro fatty acyl chain length selectivity of these LpxA orthologues is consistent with the structures of the lipid A molecules isolated from E. coli and P. aeruginosa (2) . The only known LpxA variant that does not require R-3-hydroxyacyl-ACP is that of Chlamydia trachomatis, which shows a strong preference for myristoyl-ACP over R-3-hydroxymyristoyl-ACP (21) . E. coli LpxA is inhibited by myristoyl-ACP (8) .
The crystal structure of E. coli LpxA was first determined in 1995 at a resolution of 2.6 Å in the absence of substrates or inhibitors (16) . A structure of Helicobacter pylori LpxA with a bound molecule of 1-S-octyl-␤-thio-D-glucoside was subsequently determined at 2.1 Å (17) . Both LpxAs are homotrimers with an unusual secondary structure, a left-handed parallel ␤-helix (16, 17) , which is generated by 30 hexapeptide repeats. Three contiguous hexad repeats specify one turn of the ␤-helix (16) . Several other bacterial acetyl and acyl transferases, including DapD (22) , GlmU (23) , and LacA (24) , share similar repeats and possess ␤-helical domains, as do a few archaebacterial (25) and eukaryotic proteins (26) .
Sequence alignments of LpxAs from diverse bacteria reveal many conserved basic residues, including several histidine residues (18) , which cluster around a cleft in between adjacent subunits, and they function in substrate binding and catalysis (18) . H125 was proposed to be the catalytic base that activates the GlcNAc 3-OH group, facilitating the direct transfer of the acyl chain from R-3-hydroxymyristoyl-ACP (18) . A H125A substitution results in complete loss of activity (18) . A recent 3.0-Å crystal structure of E. coli LpxA with bound UDP-GlcNAc confirmed that H125 is within hydrogen-bonding distance of the 3-OH group (27) . H122, H144, H160, and R204 were proposed to be involved in substrate binding, because alanine substitutions reduced but did not eliminate activity (18) . In the LpxA/UDPGlcNAc complex, H144 is positioned to hydrogen-bond the 6-OH group of the GlcNAc moiety, and R204 contacts the ␣-P atom of UDP (27) .
G173 strongly influences acyl chain selectivity (19) and may function as a kind of hydrocarbon ruler. The G173M mutant of E. coli LpxA prefers R-3-hydroxydecanoyl-ACP, whereas activity with R-3-hydroxymyristoyl-ACP is lost (19) . The reciprocal M169G mutation of P. aeruginosa LpxA converts what is normally an R-3-hydroxydecanoyl-ACP-selective enzyme to an R-3-hydroxymyristoyl-ACP-selective enzyme (19) . H. pylori LpxA prefers 16 carbon R-3-hydroxyacyl chains (C. R. Sweet and C.R.H.R., unpublished data).
We recently described the structure of E. coli LpxA with the bound inhibitor peptide 920 (28) , which binds in a region overlapping with R-3-hydroxymyristoyl-ACP. Peptide 920 does not share sequence similarity with ACP or LpxA (28, 29) . The structures of the LpxA/peptide 920 (28) and the LpxA/UDPGlcNAc (27) complexes did not reveal how LpxA acquires its extraordinary acyl chain selectivity. Attempts to crystallize LpxA with acyl-ACP have been unsuccessful, but crystallization of LpxA with its product UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc (6, 8) had not been investigated. Here we present the crystal structures of LpxA with bound UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc at a resolution of 1.74 Å and UDP-3-O-(R-3-hydroxydecanoyl)-GlcNAc at 1.85 Å. As in the 3.0-Å LpxA/UDP-GlcNAc complex (27) , H125 is within hydrogenbonding distance of the GlcNAc 3-O atom. The positioning of G173 relative to the terminal methyl group of the R-3-hydroxymyristoyl chain explains why the LpxA G173M mutation is R-3-hydroxydecanoyl-ACP-selective and why the G173S and the G173C substitutions cannot use R-3-hydroxymyristoyl-or R-3-hydroxylauoryl-ACP (19) . Specific roles for H99, H122, H144, K76, Q73, Q161, R204, and R205 are apparent from our structures. Although the positioning of the GlcNAc moiety is identical in both the LpxA/UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc and the LpxA/UDP-3-O-(R-3-hydroxydecanoyl)-GlcNAc complexes, the conformation of the UDP moiety is distinctly different.
Results
Structure of LpxA with Bound UDP-3-O-(R-3-hydroxyacyl)-GlcNAc. The LpxA reaction is reversible, with the equilibrium favoring the reactants over products (K eq Ϸ 0.01) (8, 18) . Consequently, LpxA catalyzes the efficient deacylation of UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc in the presence of ACP to yield UDP-GlcNAc and R-3-hydroxymyristoyl-ACP (8, 18) . E. coli LpxA does not hydrolyze UDP-3-O-(R-3-hydroxyacyl)-GlcNAc in the absence of ACP (8, 18) . The enzyme was therefore crystallized in the presence of a 25-fold molar excess of either UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc or UDP-3-O-(R-3-hydroxydecanoyl)-GlcNAc. The crystals of UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc diffracted to a resolution of 1.74 Å, whereas crystals of UDP-3-O-(R-3-hydroxydecanoyl)-GlcNAc diffracted to 1.85 Å. The structures of both complexes were solved by molecular replacement, using unliganded LpxA (Protein Data Bank ID code 1LXA) as the model (16) . The asymmetric unit of both complexes was composed of one LpxA monomer with one bound UDP-3-O-(R-3-hydroxyacyl)-GlcNAc molecule. Three asymmetric units are positioned around a crystallographic threefold axis to form the biologically relevant trimer (Fig. 2) (16) . In both complexes, Ͼ98% of all amino acid residues were in favored regions of the Ramachandran plot, as determined by Molprobity (30) . The data collection and refinement statistics are presented in Table 1 .
Examination of both structures reveals that the complexes possess the same left-handed parallel ␤-helix architecture (Fig. 2 ) described for unliganded LpxA (16) . The bound products did not cause major conformational changes. Superposition of unliganded LpxA with LpxA/UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc or with LpxA/UDP-3-O-(R-3-hydroxydecanoyl)-GlcNAc revealed an average rmsd of 0.37 and 0.34 Å, respectively, for all paired C ␣ atoms. The perturbation of the side-chains was generally very minor (0.2 Å) but was more significant for some of the residues located near the ligands. In particular, the acyl chains of the ligands displaced the side chain of H160 when compared with free LpxA or the LpxA/UDP-GlcNAc complex. Superimposition of the LpxA/UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc complex and the LpxA/UDP-3-O-(R-3-hydroxydecanoyl)-GlcNAc complex gave an rmsd of 0.10 Å for all C ␣ pairs of the backbone. In both structures, the electron density of LpxA was clear and consistent for all 262 amino acids (data not shown). (2, 4) . This is a thermodynamically unfavorable reaction; therefore, LpxC catalyzes the committed step of the pathway (8).
UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc and UDP-3-O-(R-3-hydroxydecanoyl)-GlcNAc bind to E. coli LpxA in similar, but not identical, conformations (Fig. 2 , compare A and B with C and D, respectively). Each active site region accommodates one molecule of UDP-3-O-(R-3-hydroxyacyl)-GlcNAc (Fig. 2) . The electron densities of the UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc and UDP-3-O-(R-3-hydroxydecanoyl)-GlcNAc were well resolved ( Fig. 3 A and B, respectively) . Strong electron density was observed in both cases for the glucosamine ring, the acyl and acetyl chains, the phosphate residues, and the uracil moiety. The density for the ribose unit was weaker, especially in the case of UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc (Fig. 3A) . The tail of the electron density leading away from the ␤-phosphate moiety in Fig. 3A suggests the possibility that a small portion of the bound UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc may be in the alternative conformation seen for UDP-3-O-(R-3-hydroxydecanoyl)-GlcNAc.
UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc in the Active Site of LpxA.
Each molecule of UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc interacts with residues from two adjacent LpxA subunits. As illustrated in Fig. 4A , the glucosamine ring and the 3-O-(R-3-hydroxymyristoyl) moiety are positioned next to the green subunit, whereas the UDP moiety extends toward the adjacent magenta subunit. The 3-OH group of the glucosamine ring is buried. The fatty acyl chain extends from the 3-O atom into the active site cleft along the green subunit. The first four carbon atoms are almost perpendicular to the long axis of the ␤-helix (Figs. 2 B and 4A ). The rest of the hydrocarbon chain runs parallel to the ␤-helix (Figs. 2 A and 4A ). The approximate length of the 3-O-(R-3-hydroxymyristoyl) chain is 14 Å. The phosphates of the UDP moiety are solvent exposed.
UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc is supported in the active site of LpxA by multiple hydrogen bonds to conserved side chains ( Fig. 4A) , some of which were previously identified by mutagenesis as being involved in catalysis or substrate binding (18, 19) . Thirteen water molecules directly interact with the ligand. Ten of them are within hydrogen-bonding distance of the UDP moiety, and two of them hydrogen-bond the GlcNAc residue. A single water molecule interacts with the R-3-OH group of the hydroxyacyl chain in an intricate network that also engages several conserved amino acid residues (Fig. 4A) . H125 is within hydrogen-bonding distance of the GlcNAc 3-O atom (Fig. 4A) , consistent with its role as the catalytic base (18) . H122 and Q73 hydrogen-bond the R-3-OH group of the acyl chain; one well defined water molecule also hydrogen-bonds the R-3-OH group, and it forms an additional bond to H99 (Fig. 4A ). H144 and K76 (not shown for clarity) are hydrogen-bonded to the GlcNAc 6-OH group (Fig. 4A) , consistent with their location in the LpxA/UDP-GlcNAc complex. K76 also interacts with O-5 of the GlcNAc unit. The backbone nitrogen of L76 is hydrogenbonded to the acetyl group of the glucosamine ring (Fig. 4A ). The conserved Q161 side chain is hydrogen-bonded to two oxygen atoms, one on each of the phosphate residues. N198 and R205 are hydrogen-bonded to the uridine moiety (Fig. 4A ). R204 and D74 (not shown) are involved in water-mediated interactions with the ligand. (Figs. 4 and 5A) . The GlcNAc unit, the first four carbons of the fatty acyl chain, and the ␤-phosphate group superimpose very well (Figs. 4 and 5A) . However, the ␣-phosphate group and the ribose ring assume different orientations, which nevertheless allow the uracil moiety to hydrogenbond to the N198 side chain (Figs. 4 and 5A ). These observations, in conjunction with the relatively weak electron density of the ribose units (Fig. 3) , suggest some flexibility of the UDP moiety, which is influenced by the length of the acyl chain. As shown in Fig. 5B , the conformation of the UDP-GlcNAc unit in the LpxA/UDP-3-O-(R-3-hydroxydecanoyl)-GlcNAc complex is virtually the same as in the 3-Å LpxA/UDP-GlcNAc complex (27) .
UDP-3-O-(R-3-hydroxydecanoyl)-GlcNAc in the Active
Most of the interactions between the ligands and LpxA are the same in both of our structures (Fig. 4, compare A with B) . For example, H125 is within hydrogen-bonding distance of the GlcNAc 3-O atom in both cases (Fig. 4) . In addition, H122, H144, H99, K76, Q73 L76, D74, Q161, N198, and R205 are all similarly involved in substrate binding, with the exception of R204, which is directly hydrogen-bonded to the ␣-phosphate of (Fig. 4A) . The pattern of water molecules interacting with the GlcNAc and R-3-OH group is identical, but there are differences around the UDP moiety (Fig. 4, compare A with B) . The backbone N atom of the conserved G143 residue is situated 3.32-3.35 Å from the carbonyl oxygen of the hydroxyacyl chain (Fig. 4) . It may be positioned to function as the oxyanion hole during catalysis.
Acyl Chain Selectivity of E. coli LpxA. Previous studies identified G173 as being involved in acyl chain length recognition (19) . The E. coli LpxA G173M mutant and the reciprocal P. aeruginosa LpxA M169G mutant showed reversed acyl chain length selectivity in vitro and in vivo (19) . E. coli LpxA G173M is an R-3-hydroxydecanoyl-ACP-selective acyltransferase, whereas P. aeruginosa LpxA M169G is an R-3-hydroxymyristoyl-ACP- specific enzyme (19) . E. coli LpxA G173 is located on the magenta subunit, opposite the green subunit that supplies H125 (Figs. 4 and 6) . The acyl chain of UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc (yellow dots) extends deep into the active site cleft, passing by G173 and G176 (Fig. 6) . The acyl chain of UDP-3-O-(R-3-hydroxydecanoyl)-GlcNAc (not shown) terminates below G173, approximately where C9 of the R-3-hydroxymyristoyl chain would be situated (Fig. 5 ). Replacing G173 with methionine would be expected to leave enough space for a 3-hydroxydecanoyl chain but would result in a clash with a 3-hydroxymyristoyl chain. The G173M substitution might increase the affinity of the enzyme for R-3-hydroxydecanoyl-ACP (19) by providing extra hydrophobic contacts to the terminal methyl group of the R-3-hydroxydecanoyl chain.
In previous mutagenesis studies, the E. coli LpxA G173C and G173S mutants, like G173M, were found to be R-3-hydroxydecanoyl-ACP selective, but they were inactive with both R-3-hydroxymyristoyl-ACP and R-3-hydroxylauroyl-ACP (19) . This anomaly is explained by the positioning of G173 relative to the bound acyl chain (Fig. 6) . The side chains of serine and cysteine would protrude into the fatty acid binding groove (Fig. 6) and clash with the terminal methyl group of an R-3-hydroxylauroyl residue. On the basis of the structure of the LpxA/UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc complex, we suggest that H191 (Fig. 6 ) might be responsible for limiting the ability of E. coli LpxA to use acyl chains longer than 14 carbon atoms. In Helicobacter, H191 is replaced with arginine, but its side-chain is oriented differently (17) , and this would not prevent utilization of R-3-hydroxypalmitoyl-ACP. (Fig. 6) , and they support the direct transfer mechanism for the acylation of the sugar nucleotide (Fig. 7) , first deduced by site-directed mutagenesis (18) . In both of our product complexes and in the recent 3.0-Å structure of LpxA with bound UDP-GlcNAc (27) , the H125/NE2 atom is situated within hydrogen-bonding distance of the GlcNAc 3-O atom. LpxA functions via a general base mechanism (Fig. 7) in which H125 activates the glucosamine 3-OH group of UDP-GlcNAc (18), thus converting it into a better nucleophile. In our structures, H125/NE2 also is within hydrogen-bonding distance of the GlcNAc O-4 atom ( Fig.  7 ; not shown in Fig. 4 for clarity) , but the significance of this interaction is unclear. In the reverse direction, H125/NE2 would be expected to activate the SH group of ACP for attack on the ester-linkage of the hydroxyacyl chain, but our structures do not address this aspect of the mechanism. The conserved D126 side chain positions and/or stabilizes the H125 side chain by hydrogen bonding the ND1 proton (Fig. 7) . On the basis of its positioning relative to the carbonyl oxygen of the acyl chain, from which it is separated by Ϸ3.32-3.35 Å, we propose that the backbone NH group of G143 functions as the oxyanion hole during catalysis (Figs. 4 and 7) .
Discussion
Because the reverse reaction catalyzed by LpxA (Fig. 1 
) requires UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc as the acyl donor and free ACP as the acyl acceptor (18), intact UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc and UDP-3-O-(R-3-
hydroxydecanoyl)-GlcNAc are visualized in the active sites of the complexes (Fig. 2) . Conserved LpxA residues (Figs. 4 and 7) participate in binding these lipid ligands and account for the substrate specificity of the enzyme. The LpxA residues that contact the (R-3-hydroxyacyl)-GlcNAc and the ␤-phosphate units are almost identical in both structures (Fig. 4) . For instance, the side chains of H144 (Figs. 4 and 7) and K76 (omitted for clarity in Fig. 4) hydrogen-bond the GlcNAc 6-OH group; K76 also interacts with the GlcNAc O-5 atom (Fig. 7) . The backbone NH group of L75 is hydrogen-bonded to the carbonyl oxygen of the acetyl group (Fig. 4) . The H122/NE2 atom hydrogen-bonds the R-3-OH moiety of the hydroxyacyl chain (Fig. 4) . The R-3-OH group is further engaged by the side chain of Q73 and by a single, well defined water molecule (Figs. 4 and 7), which in turn is hydrogen-bonded to H99 (Figs. 4 and  7) and the backbone N of Q73 (omitted for clarity in Fig. 4) . Interestingly, H99 is replaced by threonine in C. trachomatis LpxA (21) . This substitution may account for loss of R-3-hydroxyacyl chain selectivity, because threonine cannot replace histidine as a hydrogen-bonding partner.
The conformation of the UDP moiety is distinctly different in the two complexes, arising from rotational reorientation of P-O bonds within the diphosphate unit (Fig. 5A) . Whether or not the UDP binding mode seen with UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc contributes to the more efficient catalysis seen with 14-carbon R-3-hydroxyacyl chains is uncertain. The altered UDP conformation results in a significant redistribution of water molecules around the UDP moiety and changes its interactions with some LpxA side chains. A direct interaction between an ␣-phos- Fig. 2 . Water molecules are depicted as cyan spheres. Hydrogen bonds are represented as black dashed lines. Hydrogen bonds between water molecules and the product molecule were omitted for clarity. G134, the putative oxyanion hole, is slightly too far removed from the carbonyl group of the acyl chain for H-bonding (3.32-3.35 Å), but it might be able to interact during catalysis. (B) Stereoview of the interactions between LpxA and UDP-3-O-(R-3-hydroxydecanoyl)-GlcNAc. The color scheme is the same as in Fig. 2 . The most significant differences are in the binding and orientation of the UDP moiety of the two ligands. In both structures, Q73 makes an additional hydrogen bond (not shown for clarity) via its backbone nitrogen atom to the single water molecule that is hydrogen-bonded to the R-3-OH moiety of the ligand.
phate oxygen and R204, seen in the UDP-3-O-(R-3-hydroxydecanoyl)-GlcNAc complex (Fig. 4B) , is lost when UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc is bound (Fig. 4A) . However, a new hydrogen bond appears to be formed between this ␣-phosphate oxygen and the Q161/NE2 atom in the UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc complex (Fig. 4A) . Despite the reversal of the uridine ring (Fig. 5) , the side chains of N198 and R205 retain their ability to hydrogen-bond the base effectively (Fig. 4, compare A  with B) .
E. coli LpxA is specific for the UDP moiety of UDP-GlcNAc (6), and the reasons are now structurally apparent. The space in the UDP binding pocket of LpxA is sufficient to accommodate an analogue like TDP-GlcNAc, which is used at Ϸ20% of the rate of UDP-GlcNAc (6). Other nucleotide sugars, like ADPGlcNAc and GDP-GlcNAc, are not substrates for LpxA (6) , probably because of steric hindrance. CDP-GlcNAc is similar in size to UDP-GlcNAc but also is not a substrate for LpxA (6) . Cytidine groups cannot always substitute for uridine, because of the differences in their hydrogen bonding capacity, which may be relevant in the case of LpxA (Figs. 4 and 7) .
Previous studies implicated G173 as a ''hydrocarbon ruler'' that determines acyl chain length selectivity (19) . We have now identified the fatty acid binding groove for E. coli LpxA (Figs. 2  and 6 ). In both complexes, the fatty acyl chain emerging from the sugar nucleotide initially lies perpendicular to the long axis of the ␤-helix, but it then turns and runs parallel to the helix (Figs. 2  and 5 ). The C12 acyl chain atom of UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc (Fig. 6 ) passes near G173, and the terminal methyl group (C14) is situated near H191 (Fig. 6 ). This arrangement is consistent with the finding that the G173M, G173F, G173S, and G173C substitutions do not use R-3-hydroxymyristoyl-or R-3-hydroxylauroyl-ACP, but instead display R-3-hydroxydecanoyl-ACP selectivity (Fig. 6) (19) . The G173A mutant, although greatly reduced in activity, remains somewhat selective for R-3-hydroxymyristoyl-ACP (19) , consistent with the structure (Fig. 6) . Therefore, steric hindrance is probably the main reason for the altered acyl chain length selectivity of these mutants, but it may not be the only explanation. The active site of E. coli LpxA utilizes 14-carbon acyl chains two orders of magnitude faster than 12-or 16-carbon acyl chains and three orders of magnitude faster than 10-carbon acyl chains (19) . Acyl chains that are shorter than 14 carbon atoms contribute less binding energy and therefore may be transferred at a slower rate. On the basis of the structure shown in Fig. 6 , it should be possible to design further changes in the acyl chain selectivity of LpxA. For instance, E. coli LpxA might prefer a 16-carbon hydroxyacyl chain if H191 were replaced with alanine or arginine (as seen in Helicobacter LpxA) (17) . Structures of LpxA orthologues with intrinsically different acyl chain selectivity, such as the C10-selective P. aeruginosa LpxA (31) or the C12-selective Leptospira interrogans LpxA (32), might provide further insights in the acyl chain recognition mechanism. L. interrogans LpxA displays the additional interesting feature of requiring as its acceptor substrate an analogue of UDP-GlcNAc, in which an amine replaces the GlcNAc O-3 atom (32, 33) . E. coli LpxA utilizes both of these sugar nucleotides at comparable rates but cannot synthesize the analogue (32). The positions of the atoms within the GlcNAc residue, the first four carbon and oxygen atoms of the acyl chain, and the ␤-phosphate group are positioned identically. However, the ␣-phosphate, the ribose ring, and the uracil moiety assume an entirely different orientation, which nevertheless permits the uracil moiety to hydrogen-bond to the side chain of N198 in both instances (Fig. 4) . The color scheme is the same as in Fig. 2. (B) Superimposition of the ligands in the LpxA/UDP-3-O-(R-3-hydroxydecanoyl)-GlcNAc complex and the 3-Å LpxA/UDP-GlcNAc complex (27) . Carbons of the latter ligand are green. The conformations of the GlcNAc and UDP moieties are virtually identical for these two complexes, showing that the presence of the longer R-3-hydroxymyristoyl chain exerts subtle effects on UDP binding. There are no crystal structures of LpxA with bound acyl-ACP. A few crystal or NMR structures are available for E. coli ACP and acyl-ACP (34-37), but these do not provide definitive information about the location and conformation of the phosphopantetheine moiety. Modeling studies based on chemical shift perturbations of 15 N-labeled ACP in the presence of E. coli LpxA suggest that ACP docks in the vicinity of R204 (36) . If the complex of LpxA and acyl-ACP cannot be crystallized, then crystals of LpxA with bound acyl-phosphopantetheine should be examined, because their structural analysis might provide insights into the positioning of the thioester group during catalysis in the forward direction.
E. coli LpxA is a validated target for antibiotic development (12, 28) , but few potent inhibitors, other than peptide 920 (28), have been reported. Our product complex structures should facilitate the rational design of new inhibitors that target LpxA.
Libraries of uridine analogues could be screened for initial leads (38) . The recently reported structure of LpxD ( Fig. 1) with bound UDP-GlcNAc (39) also may provide additional clues. The first six enzymes of the lipid A pathway (Fig. 1) are outstanding targets for new antibiotic discovery, and the crystal structures of the first three enzymes are now available with bound ligands and/or inhibitors (Fig. 8) . These structures provide exciting insights into the emerging area of lipid/protein structural biology. Potent LpxC inhibitors with antibiotic activity comparable to ciprofloxacin have already provided the proof of principle (14) , and should be useful for the treatment of infections caused by multidrug-resistant Gram-negative bacteria.
Materials and Methods
Reagents. Synthetic UDP-3-O-(R-3-hydroxy-decanoyl)-GlcNAc and synthetic UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc used Fig. 7 . Role of conserved LpxA residues in acyl chain selectivity and catalysis. Our structural analysis supports the previously proposed role of H125 as the catalytic base (18, 32) and further identifies the functions of various conserved side chains in substrate binding during the tetrahedral transition state, as indicated. Uncertainties remain about the positioning of the phosphopantetheine arm of ACP and the role of the conserved H160 residue (Fig. 6 ), the side chain of which is displaced by the presence of the acyl chain of the ligand. The proposed role of G143 as the oxyanion hole is inferred on the basis of the absolute conservation of this residue and its positioning near the carbonyl oxygen atoms of the ligands, as shown in Fig. 4 . for crystallography were purchased from the Alberta Research Council (Edmonton, Canada).
Sample Preparation for Crystallization. E. coli LpxA was expressed and purified as previously described (8, 18, 40) . Crystals of LpxA and product complexes were grown at 18°C by using the hanging drop vapor diffusion method (40) . Concentrated solutions of UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc or UDP-3-O-(R-3-hydroxydecanoyl)-GlcNAc were added to separate solutions of concentrated LpxA (25 mg/ml) to yield a 25-fold molar excess over enzyme monomer. Individual droplets contained equal volumes of the LpxA and ligand solutions as well as 0.8-1.4 M Na/K phosphate, pH 5.6-6.3, as generated with Hampton Research (Aliso Viejo, CA) solution HR2-223, and 30-35% DMSO. Crystalline cubes grew to Ϸ0.6 mm after 5 days. Structure Determination and Refinement. Diffraction images were reduced and scaled by using HKL2000 (41) . Phases were determined by using molecular replacement with the program MolRep (42) . The search model consisted of a single LpxA monomer from the earlier structure determination at 2.6 Å (Protein Data Bank ID code 1LXA) (16) . Iterative rounds of model building were performed by using the programs O and Coot, with rounds of simulated annealing, energy minimization, and B-factor refinement in Refmac (a part of the CCP4 suite) (43) (44) (45) . Identification of non-water solvent molecules was accomplished with iterative rounds of solvent identification in the program ARP/ warp (46) . The quality of the final model was assessed by using MolProbity and PROCHECK (30, 47) . The figures were drawn using PyMOL (DeLano Scientific, San Carlos, CA). Data collection and refinement statistics are presented in Table 1 .
We thank Drs. Jane Richardson and James Phillips of the Department of Biochemistry, Duke University Medical Center, for stimulating discussions and help with the structure analysis. This work was supported by National Institutes of Health Grant GM-51310 (to C.R.H.R.).
